nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilazapril—ACE—atherosclerosis	0.539	1	CbGaD
Cilazapril—ABCB1—Ezetimibe—atherosclerosis	0.0482	0.267	CbGbCtD
Cilazapril—ABCB1—Simvastatin—atherosclerosis	0.0448	0.248	CbGbCtD
Cilazapril—ABCB1—Pravastatin—atherosclerosis	0.0438	0.243	CbGbCtD
Cilazapril—ABCB1—Lovastatin—atherosclerosis	0.0438	0.243	CbGbCtD
Cilazapril—ACE—thoracic aorta—atherosclerosis	0.0196	0.207	CbGeAlD
Cilazapril—ACE—renal artery—atherosclerosis	0.0159	0.168	CbGeAlD
Cilazapril—ACE—arteriole—atherosclerosis	0.0128	0.135	CbGeAlD
Cilazapril—ACE—tunica intima—atherosclerosis	0.00909	0.0957	CbGeAlD
Cilazapril—ACE—vein—atherosclerosis	0.00763	0.0804	CbGeAlD
Cilazapril—ACE—umbilical vein—atherosclerosis	0.00554	0.0584	CbGeAlD
Cilazapril—ACE—hindlimb—atherosclerosis	0.00507	0.0534	CbGeAlD
Cilazapril—ACE—appendage—atherosclerosis	0.00435	0.0459	CbGeAlD
Cilazapril—ACE—artery—atherosclerosis	0.00311	0.0328	CbGeAlD
Cilazapril—ACE—endothelium—atherosclerosis	0.00263	0.0277	CbGeAlD
Cilazapril—ACE—blood vessel—atherosclerosis	0.00242	0.0255	CbGeAlD
Cilazapril—ACE—connective tissue—atherosclerosis	0.00124	0.0131	CbGeAlD
Cilazapril—ACE—cardiovascular system—atherosclerosis	0.00108	0.0114	CbGeAlD
Cilazapril—ACE—adipose tissue—atherosclerosis	0.000953	0.01	CbGeAlD
Cilazapril—SLC15A1—liver—atherosclerosis	0.000932	0.00982	CbGeAlD
Cilazapril—ABCB1—blood vessel—atherosclerosis	0.000853	0.00899	CbGeAlD
Cilazapril—Fosinopril—ACE—atherosclerosis	0.00067	0.106	CrCbGaD
Cilazapril—ACE—liver—atherosclerosis	0.000668	0.00704	CbGeAlD
Cilazapril—Perindopril—ACE—atherosclerosis	0.000546	0.0862	CrCbGaD
Cilazapril—Spirapril—ACE—atherosclerosis	0.00054	0.0853	CrCbGaD
Cilazapril—ACE—ACE Inhibitor Pathway—KNG1—atherosclerosis	0.00052	0.0817	CbGpPWpGaD
Cilazapril—Moexipril—ACE—atherosclerosis	0.000518	0.0817	CrCbGaD
Cilazapril—ACE—ACE Inhibitor Pathway—AGTR1—atherosclerosis	0.000517	0.0812	CbGpPWpGaD
Cilazapril—Mitiglinide—PPARG—atherosclerosis	0.000516	0.0814	CrCbGaD
Cilazapril—Benazepril—MTHFR—atherosclerosis	0.000514	0.0811	CrCbGaD
Cilazapril—Quinapril—ACE—atherosclerosis	0.000482	0.076	CrCbGaD
Cilazapril—Lisinopril—ACE—atherosclerosis	0.000482	0.076	CrCbGaD
Cilazapril—Trandolapril—ACE—atherosclerosis	0.000466	0.0736	CrCbGaD
Cilazapril—Ramipril—ACE—atherosclerosis	0.000466	0.0736	CrCbGaD
Cilazapril—Muscle spasms—Lovastatin—atherosclerosis	0.000456	0.00264	CcSEcCtD
Cilazapril—Visual impairment—Niacin—atherosclerosis	0.000451	0.00261	CcSEcCtD
Cilazapril—Alopecia—Simvastatin—atherosclerosis	0.00045	0.0026	CcSEcCtD
Cilazapril—Muscle spasms—Ezetimibe—atherosclerosis	0.000447	0.00259	CcSEcCtD
Cilazapril—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000447	0.00259	CcSEcCtD
Cilazapril—Tremor—Lovastatin—atherosclerosis	0.000444	0.00257	CcSEcCtD
Cilazapril—Visual impairment—Pravastatin—atherosclerosis	0.000444	0.00257	CcSEcCtD
Cilazapril—Ill-defined disorder—Lovastatin—atherosclerosis	0.00044	0.00254	CcSEcCtD
Cilazapril—Flatulence—Simvastatin—atherosclerosis	0.000437	0.00253	CcSEcCtD
Cilazapril—Tinnitus—Niacin—atherosclerosis	0.000436	0.00252	CcSEcCtD
Cilazapril—Erythema multiforme—Pravastatin—atherosclerosis	0.000436	0.00252	CcSEcCtD
Cilazapril—Dysgeusia—Simvastatin—atherosclerosis	0.000434	0.00251	CcSEcCtD
Cilazapril—Flushing—Niacin—atherosclerosis	0.000434	0.00251	CcSEcCtD
Cilazapril—Angioedema—Lovastatin—atherosclerosis	0.000433	0.00251	CcSEcCtD
Cilazapril—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000432	0.00249	CcSEcCtD
Cilazapril—Anaemia—Ezetimibe—atherosclerosis	0.00043	0.00249	CcSEcCtD
Cilazapril—Tinnitus—Pravastatin—atherosclerosis	0.00043	0.00248	CcSEcCtD
Cilazapril—Malaise—Lovastatin—atherosclerosis	0.000428	0.00247	CcSEcCtD
Cilazapril—Cardiac disorder—Pravastatin—atherosclerosis	0.000428	0.00247	CcSEcCtD
Cilazapril—Flushing—Pravastatin—atherosclerosis	0.000428	0.00247	CcSEcCtD
Cilazapril—Muscle spasms—Simvastatin—atherosclerosis	0.000427	0.00247	CcSEcCtD
Cilazapril—Vertigo—Lovastatin—atherosclerosis	0.000426	0.00246	CcSEcCtD
Cilazapril—Angioedema—Ezetimibe—atherosclerosis	0.000425	0.00246	CcSEcCtD
Cilazapril—Angiopathy—Niacin—atherosclerosis	0.000425	0.00245	CcSEcCtD
Cilazapril—Leukopenia—Lovastatin—atherosclerosis	0.000425	0.00245	CcSEcCtD
Cilazapril—Chills—Niacin—atherosclerosis	0.00042	0.00243	CcSEcCtD
Cilazapril—Malaise—Ezetimibe—atherosclerosis	0.000419	0.00242	CcSEcCtD
Cilazapril—Benazepril—ACE—atherosclerosis	0.000419	0.0661	CrCbGaD
Cilazapril—Arrhythmia—Niacin—atherosclerosis	0.000418	0.00242	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000416	0.00241	CcSEcCtD
Cilazapril—Tremor—Simvastatin—atherosclerosis	0.000416	0.0024	CcSEcCtD
Cilazapril—Alopecia—Niacin—atherosclerosis	0.000413	0.00239	CcSEcCtD
Cilazapril—Chills—Pravastatin—atherosclerosis	0.000413	0.00239	CcSEcCtD
Cilazapril—Insomnia—Rosuvastatin—atherosclerosis	0.000413	0.00239	CcSEcCtD
Cilazapril—Ill-defined disorder—Simvastatin—atherosclerosis	0.000412	0.00238	CcSEcCtD
Cilazapril—Arrhythmia—Pravastatin—atherosclerosis	0.000412	0.00238	CcSEcCtD
Cilazapril—Palpitations—Ezetimibe—atherosclerosis	0.000411	0.00238	CcSEcCtD
Cilazapril—Paraesthesia—Rosuvastatin—atherosclerosis	0.00041	0.00237	CcSEcCtD
Cilazapril—Anaemia—Simvastatin—atherosclerosis	0.00041	0.00237	CcSEcCtD
Cilazapril—Alopecia—Pravastatin—atherosclerosis	0.000407	0.00235	CcSEcCtD
Cilazapril—Cough—Ezetimibe—atherosclerosis	0.000406	0.00235	CcSEcCtD
Cilazapril—Angioedema—Simvastatin—atherosclerosis	0.000405	0.00234	CcSEcCtD
Cilazapril—Chest pain—Lovastatin—atherosclerosis	0.000404	0.00233	CcSEcCtD
Cilazapril—Arthralgia—Lovastatin—atherosclerosis	0.000404	0.00233	CcSEcCtD
Cilazapril—Myalgia—Lovastatin—atherosclerosis	0.000404	0.00233	CcSEcCtD
Cilazapril—Anxiety—Lovastatin—atherosclerosis	0.000402	0.00233	CcSEcCtD
Cilazapril—Dyspepsia—Rosuvastatin—atherosclerosis	0.000402	0.00232	CcSEcCtD
Cilazapril—Hypertension—Ezetimibe—atherosclerosis	0.000402	0.00232	CcSEcCtD
Cilazapril—Flatulence—Niacin—atherosclerosis	0.000401	0.00232	CcSEcCtD
Cilazapril—Malaise—Simvastatin—atherosclerosis	0.0004	0.00231	CcSEcCtD
Cilazapril—Tension—Niacin—atherosclerosis	0.0004	0.00231	CcSEcCtD
Cilazapril—Discomfort—Lovastatin—atherosclerosis	0.000399	0.00231	CcSEcCtD
Cilazapril—Vertigo—Simvastatin—atherosclerosis	0.000399	0.0023	CcSEcCtD
Cilazapril—Leukopenia—Simvastatin—atherosclerosis	0.000397	0.0023	CcSEcCtD
Cilazapril—Arthralgia—Ezetimibe—atherosclerosis	0.000396	0.00229	CcSEcCtD
Cilazapril—Chest pain—Ezetimibe—atherosclerosis	0.000396	0.00229	CcSEcCtD
Cilazapril—Myalgia—Ezetimibe—atherosclerosis	0.000396	0.00229	CcSEcCtD
Cilazapril—Nervousness—Niacin—atherosclerosis	0.000396	0.00229	CcSEcCtD
Cilazapril—Flatulence—Pravastatin—atherosclerosis	0.000395	0.00228	CcSEcCtD
Cilazapril—Dry mouth—Lovastatin—atherosclerosis	0.000395	0.00228	CcSEcCtD
Cilazapril—Tension—Pravastatin—atherosclerosis	0.000394	0.00228	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000393	0.00227	CcSEcCtD
Cilazapril—Dysgeusia—Pravastatin—atherosclerosis	0.000393	0.00227	CcSEcCtD
Cilazapril—Muscle spasms—Niacin—atherosclerosis	0.000392	0.00226	CcSEcCtD
Cilazapril—Discomfort—Ezetimibe—atherosclerosis	0.000391	0.00226	CcSEcCtD
Cilazapril—Pain—Rosuvastatin—atherosclerosis	0.000391	0.00226	CcSEcCtD
Cilazapril—Constipation—Rosuvastatin—atherosclerosis	0.000391	0.00226	CcSEcCtD
Cilazapril—Confusional state—Lovastatin—atherosclerosis	0.00039	0.00226	CcSEcCtD
Cilazapril—Nervousness—Pravastatin—atherosclerosis	0.00039	0.00225	CcSEcCtD
Cilazapril—Dry mouth—Ezetimibe—atherosclerosis	0.000387	0.00224	CcSEcCtD
Cilazapril—Muscle spasms—Pravastatin—atherosclerosis	0.000386	0.00223	CcSEcCtD
Cilazapril—Confusional state—Ezetimibe—atherosclerosis	0.000383	0.00221	CcSEcCtD
Cilazapril—ACE—Metabolism of Angiotensinogen to Angiotensins—AGT—atherosclerosis	0.000382	0.06	CbGpPWpGaD
Cilazapril—ABCB1—cardiovascular system—atherosclerosis	0.00038	0.00401	CbGeAlD
Cilazapril—Thrombocytopenia—Lovastatin—atherosclerosis	0.000379	0.00219	CcSEcCtD
Cilazapril—Arthralgia—Simvastatin—atherosclerosis	0.000378	0.00218	CcSEcCtD
Cilazapril—Chest pain—Simvastatin—atherosclerosis	0.000378	0.00218	CcSEcCtD
Cilazapril—Myalgia—Simvastatin—atherosclerosis	0.000378	0.00218	CcSEcCtD
Cilazapril—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000376	0.00218	CcSEcCtD
Cilazapril—Anxiety—Simvastatin—atherosclerosis	0.000376	0.00218	CcSEcCtD
Cilazapril—Tremor—Pravastatin—atherosclerosis	0.000376	0.00217	CcSEcCtD
Cilazapril—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000373	0.00216	CcSEcCtD
Cilazapril—Discomfort—Simvastatin—atherosclerosis	0.000373	0.00216	CcSEcCtD
Cilazapril—Angioedema—Niacin—atherosclerosis	0.000372	0.00215	CcSEcCtD
Cilazapril—Ill-defined disorder—Pravastatin—atherosclerosis	0.000372	0.00215	CcSEcCtD
Cilazapril—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000372	0.00215	CcSEcCtD
Cilazapril—Anaemia—Pravastatin—atherosclerosis	0.000371	0.00214	CcSEcCtD
Cilazapril—Anorexia—Lovastatin—atherosclerosis	0.000369	0.00213	CcSEcCtD
Cilazapril—Skin disorder—Ezetimibe—atherosclerosis	0.000369	0.00213	CcSEcCtD
Cilazapril—Angioedema—Pravastatin—atherosclerosis	0.000366	0.00212	CcSEcCtD
Cilazapril—Vertigo—Niacin—atherosclerosis	0.000366	0.00212	CcSEcCtD
Cilazapril—Syncope—Niacin—atherosclerosis	0.000365	0.00211	CcSEcCtD
Cilazapril—Confusional state—Simvastatin—atherosclerosis	0.000365	0.00211	CcSEcCtD
Cilazapril—Leukopenia—Niacin—atherosclerosis	0.000365	0.00211	CcSEcCtD
Cilazapril—ACE—ACE Inhibitor Pathway—AGT—atherosclerosis	0.000364	0.0571	CbGpPWpGaD
Cilazapril—Urticaria—Rosuvastatin—atherosclerosis	0.000363	0.0021	CcSEcCtD
Cilazapril—Oedema—Simvastatin—atherosclerosis	0.000362	0.00209	CcSEcCtD
Cilazapril—Malaise—Pravastatin—atherosclerosis	0.000362	0.00209	CcSEcCtD
Cilazapril—Abdominal pain—Rosuvastatin—atherosclerosis	0.000361	0.00209	CcSEcCtD
Cilazapril—Vertigo—Pravastatin—atherosclerosis	0.00036	0.00208	CcSEcCtD
Cilazapril—Palpitations—Niacin—atherosclerosis	0.00036	0.00208	CcSEcCtD
Cilazapril—Leukopenia—Pravastatin—atherosclerosis	0.000359	0.00208	CcSEcCtD
Cilazapril—Loss of consciousness—Niacin—atherosclerosis	0.000358	0.00207	CcSEcCtD
Cilazapril—Cough—Niacin—atherosclerosis	0.000355	0.00205	CcSEcCtD
Cilazapril—Thrombocytopenia—Simvastatin—atherosclerosis	0.000354	0.00205	CcSEcCtD
Cilazapril—Enalapril—ACE—atherosclerosis	0.000353	0.0558	CrCbGaD
Cilazapril—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000353	0.00204	CcSEcCtD
Cilazapril—Insomnia—Lovastatin—atherosclerosis	0.00035	0.00202	CcSEcCtD
Cilazapril—Cough—Pravastatin—atherosclerosis	0.00035	0.00202	CcSEcCtD
Cilazapril—Paraesthesia—Lovastatin—atherosclerosis	0.000348	0.00201	CcSEcCtD
Cilazapril—Arthralgia—Niacin—atherosclerosis	0.000347	0.002	CcSEcCtD
Cilazapril—Myalgia—Niacin—atherosclerosis	0.000347	0.002	CcSEcCtD
Cilazapril—Hypertension—Pravastatin—atherosclerosis	0.000346	0.002	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000346	0.002	CcSEcCtD
Cilazapril—Anorexia—Simvastatin—atherosclerosis	0.000345	0.00199	CcSEcCtD
Cilazapril—Dyspnoea—Lovastatin—atherosclerosis	0.000345	0.00199	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000344	0.00199	CcSEcCtD
Cilazapril—Insomnia—Ezetimibe—atherosclerosis	0.000343	0.00198	CcSEcCtD
Cilazapril—Chest pain—Pravastatin—atherosclerosis	0.000341	0.00197	CcSEcCtD
Cilazapril—Myalgia—Pravastatin—atherosclerosis	0.000341	0.00197	CcSEcCtD
Cilazapril—Arthralgia—Pravastatin—atherosclerosis	0.000341	0.00197	CcSEcCtD
Cilazapril—Paraesthesia—Ezetimibe—atherosclerosis	0.000341	0.00197	CcSEcCtD
Cilazapril—Dyspepsia—Lovastatin—atherosclerosis	0.000341	0.00197	CcSEcCtD
Cilazapril—Anxiety—Pravastatin—atherosclerosis	0.00034	0.00197	CcSEcCtD
Cilazapril—Dry mouth—Niacin—atherosclerosis	0.000339	0.00196	CcSEcCtD
Cilazapril—Dyspnoea—Ezetimibe—atherosclerosis	0.000338	0.00196	CcSEcCtD
Cilazapril—Discomfort—Pravastatin—atherosclerosis	0.000337	0.00195	CcSEcCtD
Cilazapril—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000337	0.00195	CcSEcCtD
Cilazapril—Decreased appetite—Lovastatin—atherosclerosis	0.000336	0.00195	CcSEcCtD
Cilazapril—ABCB1—adipose tissue—atherosclerosis	0.000335	0.00353	CbGeAlD
Cilazapril—Dyspepsia—Ezetimibe—atherosclerosis	0.000334	0.00193	CcSEcCtD
Cilazapril—Fatigue—Lovastatin—atherosclerosis	0.000334	0.00193	CcSEcCtD
Cilazapril—Oedema—Niacin—atherosclerosis	0.000332	0.00192	CcSEcCtD
Cilazapril—Constipation—Lovastatin—atherosclerosis	0.000331	0.00191	CcSEcCtD
Cilazapril—Pain—Lovastatin—atherosclerosis	0.000331	0.00191	CcSEcCtD
Cilazapril—Confusional state—Pravastatin—atherosclerosis	0.00033	0.00191	CcSEcCtD
Cilazapril—Decreased appetite—Ezetimibe—atherosclerosis	0.00033	0.00191	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00033	0.00191	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000328	0.00189	CcSEcCtD
Cilazapril—Asthenia—Rosuvastatin—atherosclerosis	0.000328	0.00189	CcSEcCtD
Cilazapril—Insomnia—Simvastatin—atherosclerosis	0.000327	0.00189	CcSEcCtD
Cilazapril—Oedema—Pravastatin—atherosclerosis	0.000327	0.00189	CcSEcCtD
Cilazapril—Fatigue—Ezetimibe—atherosclerosis	0.000327	0.00189	CcSEcCtD
Cilazapril—Shock—Niacin—atherosclerosis	0.000327	0.00189	CcSEcCtD
Cilazapril—Paraesthesia—Simvastatin—atherosclerosis	0.000325	0.00188	CcSEcCtD
Cilazapril—Pain—Ezetimibe—atherosclerosis	0.000325	0.00188	CcSEcCtD
Cilazapril—Constipation—Ezetimibe—atherosclerosis	0.000325	0.00188	CcSEcCtD
Cilazapril—Tachycardia—Niacin—atherosclerosis	0.000324	0.00188	CcSEcCtD
Cilazapril—Pruritus—Rosuvastatin—atherosclerosis	0.000323	0.00187	CcSEcCtD
Cilazapril—Skin disorder—Niacin—atherosclerosis	0.000323	0.00187	CcSEcCtD
Cilazapril—Dyspnoea—Simvastatin—atherosclerosis	0.000323	0.00187	CcSEcCtD
Cilazapril—Hyperhidrosis—Niacin—atherosclerosis	0.000321	0.00186	CcSEcCtD
Cilazapril—Thrombocytopenia—Pravastatin—atherosclerosis	0.00032	0.00185	CcSEcCtD
Cilazapril—Feeling abnormal—Lovastatin—atherosclerosis	0.000319	0.00184	CcSEcCtD
Cilazapril—Dyspepsia—Simvastatin—atherosclerosis	0.000319	0.00184	CcSEcCtD
Cilazapril—Anorexia—Niacin—atherosclerosis	0.000317	0.00183	CcSEcCtD
Cilazapril—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000317	0.00183	CcSEcCtD
Cilazapril—Hyperhidrosis—Pravastatin—atherosclerosis	0.000316	0.00183	CcSEcCtD
Cilazapril—Decreased appetite—Simvastatin—atherosclerosis	0.000315	0.00182	CcSEcCtD
Cilazapril—Feeling abnormal—Ezetimibe—atherosclerosis	0.000313	0.00181	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000313	0.00181	CcSEcCtD
Cilazapril—Diarrhoea—Rosuvastatin—atherosclerosis	0.000313	0.00181	CcSEcCtD
Cilazapril—Fatigue—Simvastatin—atherosclerosis	0.000312	0.0018	CcSEcCtD
Cilazapril—Anorexia—Pravastatin—atherosclerosis	0.000312	0.0018	CcSEcCtD
Cilazapril—Hypotension—Niacin—atherosclerosis	0.000311	0.0018	CcSEcCtD
Cilazapril—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00031	0.00179	CcSEcCtD
Cilazapril—Pain—Simvastatin—atherosclerosis	0.00031	0.00179	CcSEcCtD
Cilazapril—Constipation—Simvastatin—atherosclerosis	0.00031	0.00179	CcSEcCtD
Cilazapril—Urticaria—Lovastatin—atherosclerosis	0.000307	0.00178	CcSEcCtD
Cilazapril—Abdominal pain—Lovastatin—atherosclerosis	0.000306	0.00177	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000303	0.00175	CcSEcCtD
Cilazapril—Dizziness—Rosuvastatin—atherosclerosis	0.000302	0.00175	CcSEcCtD
Cilazapril—Urticaria—Ezetimibe—atherosclerosis	0.000302	0.00174	CcSEcCtD
Cilazapril—Insomnia—Niacin—atherosclerosis	0.000301	0.00174	CcSEcCtD
Cilazapril—Abdominal pain—Ezetimibe—atherosclerosis	0.0003	0.00173	CcSEcCtD
Cilazapril—Paraesthesia—Niacin—atherosclerosis	0.000299	0.00173	CcSEcCtD
Cilazapril—Feeling abnormal—Simvastatin—atherosclerosis	0.000298	0.00172	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000298	0.00172	CcSEcCtD
Cilazapril—Dyspnoea—Niacin—atherosclerosis	0.000296	0.00171	CcSEcCtD
Cilazapril—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000296	0.00171	CcSEcCtD
Cilazapril—Insomnia—Pravastatin—atherosclerosis	0.000296	0.00171	CcSEcCtD
Cilazapril—Somnolence—Niacin—atherosclerosis	0.000296	0.00171	CcSEcCtD
Cilazapril—Paraesthesia—Pravastatin—atherosclerosis	0.000294	0.0017	CcSEcCtD
Cilazapril—Dyspepsia—Niacin—atherosclerosis	0.000293	0.00169	CcSEcCtD
Cilazapril—Dyspnoea—Pravastatin—atherosclerosis	0.000292	0.00169	CcSEcCtD
Cilazapril—Decreased appetite—Niacin—atherosclerosis	0.000289	0.00167	CcSEcCtD
Cilazapril—Dyspepsia—Pravastatin—atherosclerosis	0.000288	0.00167	CcSEcCtD
Cilazapril—Rash—Rosuvastatin—atherosclerosis	0.000288	0.00166	CcSEcCtD
Cilazapril—Dermatitis—Rosuvastatin—atherosclerosis	0.000288	0.00166	CcSEcCtD
Cilazapril—Urticaria—Simvastatin—atherosclerosis	0.000288	0.00166	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Niacin—atherosclerosis	0.000287	0.00166	CcSEcCtD
Cilazapril—Abdominal pain—Simvastatin—atherosclerosis	0.000286	0.00165	CcSEcCtD
Cilazapril—Headache—Rosuvastatin—atherosclerosis	0.000286	0.00165	CcSEcCtD
Cilazapril—Hypersensitivity—Lovastatin—atherosclerosis	0.000285	0.00165	CcSEcCtD
Cilazapril—Decreased appetite—Pravastatin—atherosclerosis	0.000285	0.00164	CcSEcCtD
Cilazapril—Pain—Niacin—atherosclerosis	0.000284	0.00164	CcSEcCtD
Cilazapril—Fatigue—Pravastatin—atherosclerosis	0.000282	0.00163	CcSEcCtD
Cilazapril—ACE—Peptide hormone metabolism—PLA2G7—atherosclerosis	0.00028	0.044	CbGpPWpGaD
Cilazapril—Constipation—Pravastatin—atherosclerosis	0.00028	0.00162	CcSEcCtD
Cilazapril—Pain—Pravastatin—atherosclerosis	0.00028	0.00162	CcSEcCtD
Cilazapril—Hypersensitivity—Ezetimibe—atherosclerosis	0.00028	0.00162	CcSEcCtD
Cilazapril—Asthenia—Lovastatin—atherosclerosis	0.000278	0.00161	CcSEcCtD
Cilazapril—Pruritus—Lovastatin—atherosclerosis	0.000274	0.00158	CcSEcCtD
Cilazapril—Asthenia—Ezetimibe—atherosclerosis	0.000272	0.00157	CcSEcCtD
Cilazapril—Gastrointestinal pain—Niacin—atherosclerosis	0.000272	0.00157	CcSEcCtD
Cilazapril—Nausea—Rosuvastatin—atherosclerosis	0.000271	0.00157	CcSEcCtD
Cilazapril—Feeling abnormal—Pravastatin—atherosclerosis	0.00027	0.00156	CcSEcCtD
Cilazapril—Pruritus—Ezetimibe—atherosclerosis	0.000269	0.00155	CcSEcCtD
Cilazapril—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000268	0.00155	CcSEcCtD
Cilazapril—ACE—ACE Inhibitor Pathway—NOS3—atherosclerosis	0.000267	0.0419	CbGpPWpGaD
Cilazapril—Hypersensitivity—Simvastatin—atherosclerosis	0.000267	0.00154	CcSEcCtD
Cilazapril—Diarrhoea—Lovastatin—atherosclerosis	0.000265	0.00153	CcSEcCtD
Cilazapril—Urticaria—Niacin—atherosclerosis	0.000264	0.00153	CcSEcCtD
Cilazapril—Nateglinide—PPARG—atherosclerosis	0.000263	0.0415	CrCbGaD
Cilazapril—Abdominal pain—Niacin—atherosclerosis	0.000263	0.00152	CcSEcCtD
Cilazapril—Urticaria—Pravastatin—atherosclerosis	0.00026	0.0015	CcSEcCtD
Cilazapril—Asthenia—Simvastatin—atherosclerosis	0.00026	0.0015	CcSEcCtD
Cilazapril—Diarrhoea—Ezetimibe—atherosclerosis	0.00026	0.0015	CcSEcCtD
Cilazapril—Abdominal pain—Pravastatin—atherosclerosis	0.000259	0.0015	CcSEcCtD
Cilazapril—Pruritus—Simvastatin—atherosclerosis	0.000256	0.00148	CcSEcCtD
Cilazapril—Dizziness—Lovastatin—atherosclerosis	0.000256	0.00148	CcSEcCtD
Cilazapril—Dizziness—Ezetimibe—atherosclerosis	0.000251	0.00145	CcSEcCtD
Cilazapril—Diarrhoea—Simvastatin—atherosclerosis	0.000248	0.00143	CcSEcCtD
Cilazapril—Vomiting—Lovastatin—atherosclerosis	0.000246	0.00142	CcSEcCtD
Cilazapril—Hypersensitivity—Niacin—atherosclerosis	0.000245	0.00142	CcSEcCtD
Cilazapril—Rash—Lovastatin—atherosclerosis	0.000244	0.00141	CcSEcCtD
Cilazapril—Dermatitis—Lovastatin—atherosclerosis	0.000244	0.00141	CcSEcCtD
Cilazapril—Headache—Lovastatin—atherosclerosis	0.000242	0.0014	CcSEcCtD
Cilazapril—Vomiting—Ezetimibe—atherosclerosis	0.000241	0.0014	CcSEcCtD
Cilazapril—Hypersensitivity—Pravastatin—atherosclerosis	0.000241	0.00139	CcSEcCtD
Cilazapril—Dizziness—Simvastatin—atherosclerosis	0.000239	0.00138	CcSEcCtD
Cilazapril—Rash—Ezetimibe—atherosclerosis	0.000239	0.00138	CcSEcCtD
Cilazapril—Dermatitis—Ezetimibe—atherosclerosis	0.000239	0.00138	CcSEcCtD
Cilazapril—Asthenia—Niacin—atherosclerosis	0.000239	0.00138	CcSEcCtD
Cilazapril—Headache—Ezetimibe—atherosclerosis	0.000238	0.00137	CcSEcCtD
Cilazapril—ABCB1—liver—atherosclerosis	0.000235	0.00248	CbGeAlD
Cilazapril—Pruritus—Niacin—atherosclerosis	0.000235	0.00136	CcSEcCtD
Cilazapril—Asthenia—Pravastatin—atherosclerosis	0.000235	0.00136	CcSEcCtD
Cilazapril—Pruritus—Pravastatin—atherosclerosis	0.000232	0.00134	CcSEcCtD
Cilazapril—Vomiting—Simvastatin—atherosclerosis	0.00023	0.00133	CcSEcCtD
Cilazapril—Nausea—Lovastatin—atherosclerosis	0.00023	0.00133	CcSEcCtD
Cilazapril—Rash—Simvastatin—atherosclerosis	0.000228	0.00132	CcSEcCtD
Cilazapril—Dermatitis—Simvastatin—atherosclerosis	0.000228	0.00132	CcSEcCtD
Cilazapril—Diarrhoea—Niacin—atherosclerosis	0.000227	0.00131	CcSEcCtD
Cilazapril—Headache—Simvastatin—atherosclerosis	0.000227	0.00131	CcSEcCtD
Cilazapril—Nausea—Ezetimibe—atherosclerosis	0.000226	0.0013	CcSEcCtD
Cilazapril—Diarrhoea—Pravastatin—atherosclerosis	0.000224	0.00129	CcSEcCtD
Cilazapril—Dizziness—Niacin—atherosclerosis	0.00022	0.00127	CcSEcCtD
Cilazapril—Dizziness—Pravastatin—atherosclerosis	0.000216	0.00125	CcSEcCtD
Cilazapril—Nausea—Simvastatin—atherosclerosis	0.000215	0.00124	CcSEcCtD
Cilazapril—Vomiting—Niacin—atherosclerosis	0.000211	0.00122	CcSEcCtD
Cilazapril—Rash—Niacin—atherosclerosis	0.00021	0.00121	CcSEcCtD
Cilazapril—Dermatitis—Niacin—atherosclerosis	0.000209	0.00121	CcSEcCtD
Cilazapril—Headache—Niacin—atherosclerosis	0.000208	0.0012	CcSEcCtD
Cilazapril—Vomiting—Pravastatin—atherosclerosis	0.000208	0.0012	CcSEcCtD
Cilazapril—Rash—Pravastatin—atherosclerosis	0.000206	0.00119	CcSEcCtD
Cilazapril—Dermatitis—Pravastatin—atherosclerosis	0.000206	0.00119	CcSEcCtD
Cilazapril—ABCB1—Drug Induction of Bile Acid Pathway—CYP7A1—atherosclerosis	0.000205	0.0323	CbGpPWpGaD
Cilazapril—Headache—Pravastatin—atherosclerosis	0.000205	0.00119	CcSEcCtD
Cilazapril—Nausea—Niacin—atherosclerosis	0.000197	0.00114	CcSEcCtD
Cilazapril—Nausea—Pravastatin—atherosclerosis	0.000194	0.00112	CcSEcCtD
Cilazapril—ACE—ACE Inhibitor Pathway—TGFB1—atherosclerosis	0.000176	0.0277	CbGpPWpGaD
Cilazapril—ABCB1—ABC-family proteins mediated transport—ABCG4—atherosclerosis	0.000164	0.0258	CbGpPWpGaD
Cilazapril—ACE—Peptide hormone metabolism—GHRL—atherosclerosis	0.000163	0.0257	CbGpPWpGaD
Cilazapril—ABCB1—ABC-family proteins mediated transport—ABCG8—atherosclerosis	0.000157	0.0247	CbGpPWpGaD
Cilazapril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—atherosclerosis	0.00013	0.0204	CbGpPWpGaD
Cilazapril—ABCB1—ABC-family proteins mediated transport—ABCG1—atherosclerosis	0.000124	0.0195	CbGpPWpGaD
Cilazapril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP7A1—atherosclerosis	0.000118	0.0185	CbGpPWpGaD
Cilazapril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—atherosclerosis	0.000102	0.016	CbGpPWpGaD
Cilazapril—ACE—Peptide hormone metabolism—AGT—atherosclerosis	0.0001	0.0158	CbGpPWpGaD
Cilazapril—Nateglinide—ALB—atherosclerosis	9.89e-05	0.0156	CrCbGaD
Cilazapril—ACE—Peptide hormone metabolism—LEP—atherosclerosis	9.83e-05	0.0155	CbGpPWpGaD
Cilazapril—ABCB1—ABC-family proteins mediated transport—ABCG5—atherosclerosis	9.75e-05	0.0153	CbGpPWpGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CSF1R—atherosclerosis	8.66e-05	0.0136	CbGpPWpGaD
Cilazapril—ACE—Peptide hormone metabolism—INS—atherosclerosis	8.4e-05	0.0132	CbGpPWpGaD
Cilazapril—ACE—Peptide hormone metabolism—IGF1—atherosclerosis	8.12e-05	0.0128	CbGpPWpGaD
Cilazapril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	6.09e-05	0.00957	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ABCG4—atherosclerosis	5.46e-05	0.00858	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—PLA2G7—atherosclerosis	5.28e-05	0.00831	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ABCG8—atherosclerosis	5.24e-05	0.00823	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ABCG4—atherosclerosis	5.07e-05	0.00797	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ABCG8—atherosclerosis	4.86e-05	0.00764	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—HSPD1—atherosclerosis	4.29e-05	0.00675	CbGpPWpGaD
Cilazapril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	4.22e-05	0.00664	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ABCG1—atherosclerosis	4.14e-05	0.00651	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ABCG1—atherosclerosis	3.84e-05	0.00604	CbGpPWpGaD
Cilazapril—ABCB1—ABC-family proteins mediated transport—APOA1—atherosclerosis	3.78e-05	0.00595	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	3.75e-05	0.0059	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—IL17A—atherosclerosis	3.65e-05	0.00574	CbGpPWpGaD
Cilazapril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	3.49e-05	0.00549	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	3.48e-05	0.00547	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—F7—atherosclerosis	3.46e-05	0.00544	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—TRPV1—atherosclerosis	3.37e-05	0.0053	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ABCG5—atherosclerosis	3.25e-05	0.0051	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CD40—atherosclerosis	3.24e-05	0.00509	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—TRPV1—atherosclerosis	3.13e-05	0.00492	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—GHRL—atherosclerosis	3.09e-05	0.00485	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—HMOX1—atherosclerosis	3.07e-05	0.00483	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	3.01e-05	0.00474	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—AGTR1—atherosclerosis	2.96e-05	0.00465	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—EDN1—atherosclerosis	2.9e-05	0.00455	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—PLAUR—atherosclerosis	2.68e-05	0.00422	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—PLG—atherosclerosis	2.62e-05	0.00412	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—IL10—atherosclerosis	2.48e-05	0.0039	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CD40LG—atherosclerosis	2.48e-05	0.0039	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—CETP—atherosclerosis	2.4e-05	0.00378	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—IGF2—atherosclerosis	2.39e-05	0.00375	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—LEP—atherosclerosis	2.36e-05	0.0037	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—FASLG—atherosclerosis	2.31e-05	0.00363	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—CETP—atherosclerosis	2.23e-05	0.00351	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—NOS2—atherosclerosis	2.2e-05	0.00345	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—PLAT—atherosclerosis	2.12e-05	0.00333	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—atherosclerosis	2.09e-05	0.00329	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—PLAT—atherosclerosis	1.97e-05	0.00309	CbGpPWpGaD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—ALB—atherosclerosis	1.96e-05	0.00309	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—MMP1—atherosclerosis	1.92e-05	0.00301	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—AGT—atherosclerosis	1.89e-05	0.00298	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—LEP—atherosclerosis	1.86e-05	0.00292	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—atherosclerosis	1.85e-05	0.00291	CbGpPWpGaD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—ALB—atherosclerosis	1.82e-05	0.00287	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—PLG—atherosclerosis	1.8e-05	0.00283	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—F2—atherosclerosis	1.75e-05	0.00275	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ABCG4—atherosclerosis	1.71e-05	0.00269	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—PLG—atherosclerosis	1.67e-05	0.00263	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	1.66e-05	0.00261	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ABCG8—atherosclerosis	1.64e-05	0.00258	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—APOB—atherosclerosis	1.59e-05	0.0025	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	1.59e-05	0.00249	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—INS—atherosclerosis	1.59e-05	0.00249	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—CCL2—atherosclerosis	1.56e-05	0.00245	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	1.54e-05	0.00243	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—IGF1—atherosclerosis	1.53e-05	0.00241	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—MMP2—atherosclerosis	1.48e-05	0.00233	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—APOB—atherosclerosis	1.48e-05	0.00232	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—IFNG—atherosclerosis	1.46e-05	0.00229	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CXCL8—atherosclerosis	1.36e-05	0.00213	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.34e-05	0.00211	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—IL1B—atherosclerosis	1.3e-05	0.00205	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ABCG1—atherosclerosis	1.3e-05	0.00204	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	1.28e-05	0.00201	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—atherosclerosis	1.27e-05	0.002	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.26e-05	0.00198	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.25e-05	0.00196	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—CXCL8—atherosclerosis	1.23e-05	0.00194	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	1.18e-05	0.00185	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.17e-05	0.00184	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	1.14e-05	0.00179	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—VEGFA—atherosclerosis	1.1e-05	0.00173	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—TRPV1—atherosclerosis	1.06e-05	0.00166	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	1.02e-05	0.0016	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—TGFB1—atherosclerosis	1.01e-05	0.00159	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ALB—atherosclerosis	9.98e-06	0.00157	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	9.62e-06	0.00151	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—TNF—atherosclerosis	9.44e-06	0.00148	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—LDLRAP1—atherosclerosis	9.44e-06	0.00148	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ALB—atherosclerosis	9.27e-06	0.00146	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PLTP—atherosclerosis	8.88e-06	0.00139	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	8.32e-06	0.00131	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—AKT1—atherosclerosis	8.12e-06	0.00128	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ABCG8—atherosclerosis	7.7e-06	0.00121	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—LTA4H—atherosclerosis	7.7e-06	0.00121	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—CETP—atherosclerosis	7.54e-06	0.00119	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	6.9e-06	0.00108	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—PLAT—atherosclerosis	6.65e-06	0.00104	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ABCG1—atherosclerosis	6.08e-06	0.000956	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	5.99e-06	0.000942	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	5.89e-06	0.000925	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—FABP4—atherosclerosis	5.72e-06	0.000899	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—LCAT—atherosclerosis	5.72e-06	0.000899	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	5.65e-06	0.000888	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—APOA4—atherosclerosis	5.61e-06	0.000882	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP7A1—atherosclerosis	5.51e-06	0.000867	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	5.44e-06	0.000855	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	5.22e-06	0.00082	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	5.14e-06	0.000808	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP27A1—atherosclerosis	5.1e-06	0.000801	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	5e-06	0.000785	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	4.99e-06	0.000784	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PLA2G2A—atherosclerosis	4.83e-06	0.000759	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—APOA2—atherosclerosis	4.83e-06	0.000759	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ALOX5AP—atherosclerosis	4.83e-06	0.000759	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ALOX15—atherosclerosis	4.83e-06	0.000759	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ABCG5—atherosclerosis	4.77e-06	0.00075	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	4.66e-06	0.000732	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—LPA—atherosclerosis	4.61e-06	0.000725	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—BGN—atherosclerosis	4.46e-06	0.000702	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—APOA5—atherosclerosis	4.42e-06	0.000695	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PLA2G1B—atherosclerosis	4.25e-06	0.000669	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	4.21e-06	0.000662	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ALOX5—atherosclerosis	4.11e-06	0.000646	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.95e-06	0.000621	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NAMPT—atherosclerosis	3.69e-06	0.000579	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—LIPC—atherosclerosis	3.66e-06	0.000576	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—APOC3—atherosclerosis	3.64e-06	0.000572	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—LDLR—atherosclerosis	3.62e-06	0.000569	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CETP—atherosclerosis	3.53e-06	0.000555	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	3.47e-06	0.000545	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SCARB1—atherosclerosis	3.38e-06	0.000532	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HMGCR—atherosclerosis	3.2e-06	0.000502	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	3.13e-06	0.000492	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ABCA1—atherosclerosis	2.85e-06	0.000448	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HMOX1—atherosclerosis	2.44e-06	0.000384	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—APOB—atherosclerosis	2.34e-06	0.000368	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GSTM1—atherosclerosis	2.28e-06	0.000358	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—LPL—atherosclerosis	2.23e-06	0.000351	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GPX1—atherosclerosis	2.18e-06	0.000343	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CD36—atherosclerosis	2.12e-06	0.000334	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—MTHFR—atherosclerosis	2.01e-06	0.000316	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PPARA—atherosclerosis	1.97e-06	0.00031	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—AGT—atherosclerosis	1.91e-06	0.0003	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—APOE—atherosclerosis	1.87e-06	0.000294	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CAV1—atherosclerosis	1.86e-06	0.000292	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—APOA1—atherosclerosis	1.85e-06	0.000291	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PIK3CG—atherosclerosis	1.69e-06	0.000266	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PPARG—atherosclerosis	1.63e-06	0.000256	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—INS—atherosclerosis	1.6e-06	0.000252	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ALB—atherosclerosis	1.47e-06	0.000231	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NOS3—atherosclerosis	1.4e-06	0.000221	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PTGS2—atherosclerosis	1.28e-06	0.000202	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—AKT1—atherosclerosis	6.45e-07	0.000101	CbGpPWpGaD
